BSTFA reacts faster and more completely than BSA, due to trifluoroacetamide leaving group The high volatility of BSTFA and its byproducts results in…

BSTFA reacts faster and more completely than BSA, due to trifluoroacetamide leaving group The high volatility of BSTFA and its byproducts results in non-co-elution of early eluting peaks Highly volatile and stable products result in low detector noise and fouling Excellent solubility and solvency Addition of TMCS catalyzes reactions of hindered functional groups and other difficult functionalities such as secondary hydroxyls and amines.

Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help expedite drugs to market. We offer unrivaled expertise in synthesis and separations services to advance your active pharmaceutical ingredients (API) from initial process development and scale-up development, to final validation and commercial manufacturing. From our extensive organic chemistry expertise and collegiate collaborations, we can deliver the added value of our innovative, proprietary chromatography products, especially those with a chiral emphasis. And, we continue to offer fine organic chemicals as we have for almost 50 years. So consider Regis an important partner in your drug development processes. We thrive on the challenges that these projects bring.